KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baxter International (BAX) Cash & Equivalents (2016 - 2025)

Baxter International (BAX) has disclosed Cash & Equivalents for 17 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 11.45% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 11.45% increase, with the full-year FY2025 number at $2.0 billion, up 11.45% from a year prior.
  • Cash & Equivalents was $2.0 billion for Q4 2025 at Baxter International, up from $1.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.7 billion in Q3 2023 to a low of $1.4 billion in Q3 2024.
  • A 5-year average of $2.4 billion and a median of $1.9 billion in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: surged 257.03% in 2023, then crashed 75.16% in 2024.
  • Baxter International's Cash & Equivalents stood at $3.0 billion in 2021, then crashed by 45.07% to $1.6 billion in 2022, then surged by 89.88% to $3.1 billion in 2023, then crashed by 42.69% to $1.8 billion in 2024, then increased by 11.45% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BAX's Cash & Equivalents are $2.0 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025).